Archives: Speakers

Based in the UK, Frank has been with CallMiner for 6 years, during which time we have seen significant business growth in the region. Frank holds a master’s degree in business administration (MBA) and a Higher National Diploma in Telecommunications engineering. He has worked in and around the contact centre and customer experience space for the last 25 years.

Emma Sturdee is an Associate Analyst at Global Data Thematic Intelligence in London, UK, where her primary responsibilities include writing reports and research. Emma holds a Bachelor of Science in Biomedical Sciences from King’s College London.

Todd Paulsen is Vice President of Formacoat, with more than 25 years of experience in management across multi-disciplined teams. Joining Formacoat as a Sales Engineer in March 2019, Todd worked his way up through the ranks to become Sales and Marketing Manager within a year amid challenging times for the industry before being promoted to the Vice President position in June 2022. Based in Minnesota, US, the Formacoat team are specialists in providing coatings for medical devices and have built up an international reputation, with Todd playing an instrumental role in their expansion in recent years.

Dr. Filip Janku is the Chief Medical Officer of Monte Rosa Therapeutics. Previously, he served as an Associate Professor of Investigational Cancer Therapeutics and Medical Director of the Clinical and Translational Research Center at MD Anderson Cancer Center. His experience includes many years in early-stage development of new cancer treatments with a focus on proof-of-concept studies of personalized cancer therapies. He has received multiple awards for his research efforts, including the Sabin Family Fellow Award, the Sidney Kimmel Scholar award, Khalifa Scholar Award, several ASCO Merit Awards and an American Association for Cancer Research Scholar-in-Training Award. He is the coauthor of more than 250 scientific articles that have appeared in peer-reviewed journals.

Dr. Janku earned his Ph.D. in Pathobiochemistry and his M.D. from Charles University in Prague. He completed his medical training at Charles University and The University of Texas MD Anderson Cancer Center.

A senior Data Analytics consultant with over 10 years of professional experience in designing analytics solutions and driving insights through web behavioural analytics, data science and machine learning methodologies to hit business objectives for leading global firms. An expert in creating data strategies and implementing analytics solutions with rich experience in building high-performance data teams, owing end-to-end accountability from data collection to insights to activation. An engaging leader that builds and inspires loyal, high-performance global teams that drive for results.
Masters in Advanced Computer Science with specialization in Machine Learning from one of the top universities in the world for computer science (The University of Manchester, UK).

Venura’s career has spanned both academia and business, primarily focused around data and technology. After a number of years working within the healthcare sector, he joined LV=General Insurance, as the Data Science Manager and then as Director of Data Science Innovation and Proposition. In this initial role, he has helped to develop the key partnership with the University of Bristol. In doing this, he has maintained close academic ties to stay at the forefront of world class research. In the January of 2022, Venura established the Innovation and Development team for Allianz in order to diversify the business portfolio outside the insurance domain.

Jo Phillips leads the Direct Wealth business at Aviva, where she and her team are democratising the notion of Wealth by making it easier for people to save and invest via a market leading digital platform. Throughout her career Jo has built teams and products that have grown businesses and transformed customer experiences. Prior to joining Aviva she held multiple executive leadership positions at American Express and BlackRock; with career highlights including include transforming American Express’ billion-dollar B2B payments platform and re-imagining BlackRock’s award-winning web and mobile ecosystem.

Jérémy Peyrol, M.Sc. in Biotechnology, joined Merck KGaA, Darmstadt, Germany in 2013 as an Upstream Development Scientist. Since then, he has been working on various projects including high-throughput process development on bacteria and yeast, and has served as Project leader on mAb and other complex protein expression systems. In his current role, Jérémy is an Upstream Innovation Expert within our Life Science Services CTDMO business, and focuses on testing and developing next generation solutions for cell line development, upstream processes, and process analytical technologies. ​